Clinical utility of circulating tumor DNA (ctDNA) during disease course of metastatic colorectal cancer (mCRC)

被引：0
|
作者：
Lim, Yoojoo [1 ]
Kim, Sheehyun [5 ]
Kang, Jun-Kyu [1 ,2 ]
Kim, Hwang-Phil [2 ,6 ]
Roh, Hanseong [1 ]
Kim, Su Yeon [1 ]
Lee, Dongin [3 ]
Bang, Duhee [1 ,3 ]
Jeong, Seung-Yong [4 ]
Park, Kyu Joo [4 ]
Han, Sae-Won [5 ,6 ]
Kim, Tae-You [1 ,5 ,6 ]
机构：
[1] IMBdx Inc, Seoul, South Korea
[2] Seoul Natl Univ Hosp, Dept Genom Med, Seoul, South Korea
[3] Yonsei Univ, Dept Chem, Seoul, South Korea
[4] Seoul Natl Univ Hosp, Dept Surg, Seoul, South Korea
[5] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
[6] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.05.203
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO41-4
引用
收藏
页码：S507 / S507
页数：1
相关论文
共 50 条
  • [21] RAS mutations concordance in circulating tumor DNA (ctDNA) and tissue in metastatic colorectal cancer (mCRC): RASANC, an AGEO prospective multicenter Study.
    Bachet, Jean-Baptiste
    Bouche, Olivier
    Taieb, Julien
    Dubreuil, Olivier
    Garcia, Marie-Line
    Meurisse, Aurelia
    Gornet, Jean-Marc
    Artru, Pascal
    Louafi, Samy
    Soularue, Emilie
    Baumgaertner, Isabelle
    Coriat, Romain
    Tougeron, David
    Lecomte, Thierry
    Mary, Florence
    Marthey, Lysiane
    Blons, Helene
    Taly, Valerie
    Bonnetain, Franck
    Laurent-Puig, Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] Clinical utility of analysing ctDNA in patients with metastatic colorectal cancer
    Tabernero, Josep
    ANNALS OF ONCOLOGY, 2021, 32 : S230 - S230
  • [23] Landscape of circulating tumor DNA (ctDNA) in metastatic breast cancer
    Davis, Andrew A.
    Jacob, Saya
    Gerratana, Lorenzo
    Shah, Ami N.
    Wehbe, Firas
    Katam, Neelima
    Zhang, Qiang
    Flaum, Lisa
    Siziopikou, Kalliopi
    Platanias, Leonidas C.
    Gradishar, William J.
    Behdad, Amir
    Cristofanilli, Massimo
    CANCER RESEARCH, 2020, 80 (04)
  • [24] A randomized study evaluating tailoring of advanced/metastatic colorectal cancer (mCRC) therapy using circulating tumor DNA (ctDNA): TACT-D
    Raghav, Kanwal Pratap Singh
    Xiao, Lianchun
    Lewis, Courtney
    Zeller, Brittany E.
    Overman, Michael J.
    Huey, Ryan W.
    Dasari, Arvind
    Chang, Kyle
    Quinn, Katie
    Shen, John Paul Y. C.
    Parseghian, Christine Megerdichian
    Willis, Jason
    Ludford, Kaysia
    Morris, Van K., II
    Wolff, Robert A.
    Wang, Xin Shelley
    Drusbosky, Leylah
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17_SUPPL) : LBA3557 - LBA3557
  • [25] Clinical application of circulating tumor DNA (ctDNA) in patients with metastatic gastric cancer.
    Hong, Moonki
    Lee, Kwang Seob
    Park, Sejung
    Kim, Kyoo Hyun
    Kim, Hyunwook
    Che, Jingmin
    Kwon, Woo Sun
    Lee, Choong-kun
    Jung, Minkyu
    Chung, Hyun Cheol Cheol
    Shin, Saeam
    Lee, Seung-Tae
    Choi, Jong Rak
    Rha, Sun Young
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 441 - 441
  • [26] Utility of circulating tumor DNA (ctDNA) versus tumor tissue genotyping for enrollment of patients with metastatic colorectal cancer (mCRC) to matched clinical trials: SCRUM-Japan GI-SCREEN and GOZILA combined analysis.
    Nakamura, Yoshiaki
    Taniguchi, Hiroya
    Bando, Hideaki
    Esaki, Taito
    Komatsu, Yoshito
    Kato, Ken
    Takahashi, Naoki
    Kagawa, Yoshinori
    Kato, Takeshi
    Nishina, Tomohiro
    Satoh, Taroh
    Oki, Eiji
    Sunakawa, Yu
    Shiozawa, Manabu
    Yamamoto, Yoshiyuki
    Kawakami, Hisato
    Denda, Tadamichi
    Ohtsu, Atsushi
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [27] Detection and description of ERBB2 amplification using circulating cell free tumor DNA (ctDNA) genomic analysis in metastatic colorectal cancer (mCRC).
    Raghav, Kanwal Pratap Singh
    Loree, Jonathan M.
    Morris, Jeffrey
    Manuel, Shanequa
    Crosby, Shadarra
    Meric-Bernstam, Funda
    Menter, David
    Raymond, Victoria
    Lanman, Richard B.
    Talasaz, AmirAli
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [28] Circulating tumor DNA (ctDNA) heterogeneity as first- and third-line treatment in patients (pts) with metastatic colorectal cancer (mCRC) treated with panitumumab
    Parseghian, Christine Megerdichian
    Beutner, Karl
    Boedigheimer, Michael
    Ruff, Paul
    Price, Timothy Jay
    Kim, Tae Won
    Fakih, Marwan
    Ang, Agnes
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [29] Nationwide Cancer Genome Screening Project Using Circulating Tumor DNA Analysis for Metastatic Colorectal Cancer (mCRC)
    Yoshino, Takayuki
    CANCER SCIENCE, 2018, 109 : 1074 - 1074
  • [30] Clinical utility of comprehensive circulating tumor DNA (ctDNA) testing compared to standard-of-care (SoC) tissue testing in first-line (1L) metastatic colorectal cancer (mCRC) patients (pts).
    Benavides, Manuel
    Alcaide, Julia
    Alvarez, Martina
    Torres, Esperanza
    Sevilla, Isabel
    Calle, Silvia Gil
    Reyna, Carmen
    Ales, Inmaculada
    Duran, Gema
    Wolman, Roberto
    Cazorla, Mireya
    Gallego, Pedro Jimenez
    Lopez, Irene
    Cantero, Alexandra
    Godoy, Ana
    Lanman, Richard B.
    Faull, Iris
    Odegaard, Justin
    Kim, Il Jin
    Alba, Emilio
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
12345